MESCHIARI, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.494
EU - Europa 4.311
AS - Asia 1.386
SA - Sud America 77
AF - Africa 19
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.303
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.373
IT - Italia 1.973
GB - Regno Unito 827
SG - Singapore 452
SE - Svezia 431
CN - Cina 334
DE - Germania 278
HK - Hong Kong 235
FI - Finlandia 145
ID - Indonesia 140
FR - Francia 124
CA - Canada 114
RU - Federazione Russa 86
BG - Bulgaria 77
NL - Olanda 64
LT - Lituania 52
IR - Iran 48
TR - Turchia 45
IN - India 44
ES - Italia 38
IE - Irlanda 34
SI - Slovenia 30
UA - Ucraina 30
BR - Brasile 27
CZ - Repubblica Ceca 25
VN - Vietnam 24
BE - Belgio 23
MY - Malesia 17
CO - Colombia 15
CL - Cile 13
AR - Argentina 12
RO - Romania 12
CH - Svizzera 10
PL - Polonia 10
AU - Australia 9
JP - Giappone 9
EG - Egitto 6
GR - Grecia 6
HU - Ungheria 6
PH - Filippine 6
SA - Arabia Saudita 6
TH - Thailandia 6
ZA - Sudafrica 6
EC - Ecuador 5
LV - Lettonia 5
PK - Pakistan 5
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
EU - Europa 3
MD - Moldavia 3
MK - Macedonia 3
NO - Norvegia 3
PT - Portogallo 3
SD - Sudan 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
BZ - Belize 2
GE - Georgia 2
HR - Croazia 2
IL - Israele 2
KR - Corea 2
KZ - Kazakistan 2
MA - Marocco 2
MC - Monaco 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
EE - Estonia 1
IQ - Iraq 1
JO - Giordania 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MR - Mauritania 1
MX - Messico 1
NZ - Nuova Zelanda 1
RS - Serbia 1
UG - Uganda 1
Totale 12.303
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.214
Fairfield 779
Southend 653
Chandler 638
Ashburn 574
Singapore 353
Nyköping 333
Woodbridge 302
Cambridge 288
Houston 277
Seattle 259
Hong Kong 227
Wilmington 207
Modena 155
New York 142
San Diego 137
Jakarta 136
Rome 128
Helsinki 126
Bologna 123
Milan 121
Ann Arbor 114
Princeton 76
Sofia 68
London 59
Beijing 57
Bremen 55
Munich 52
Shanghai 51
Parma 50
Toronto 48
Dearborn 43
Jacksonville 43
North York 37
Redwood City 36
Fremont 33
Naples 33
Reggio Emilia 33
Boardman 29
Moscow 27
Dublin 26
Los Angeles 26
Paris 23
Amsterdam 22
Catania 22
Chicago 21
Florence 21
Grafing 21
Brussels 20
Des Moines 20
Dong Ket 20
Izmir 20
Brno 19
Frankfurt am Main 19
Falls Church 18
Madrid 18
Tabriz 18
Reggio Nell'emilia 17
Palermo 16
Verona 16
Bari 15
Norwalk 15
Beauharnois 14
Rimini 14
Turin 14
Bergamo 13
Padova 13
Roncoferraro 13
Bagnacavallo 12
Eugene 12
Genoa 12
San Jose 12
Lappeenranta 11
Chiswick 10
Córdoba 10
Nanjing 10
Ottawa 10
Buffalo 9
Kilburn 9
Mumbai 9
Washington 9
Brescia 8
Dallas 8
Guangzhou 8
Hamm 8
Hounslow 8
Ravenna 8
Trieste 8
Vicenza 8
Bogotá 7
Carpi 7
Chengdu 7
Milwaukee 7
Murcia 7
Phoenix 7
Rho 7
Santiago 7
Stockholm 7
Trento 7
Castelnuovo Rangone 6
Totale 8.905
Salva come PNG Salva come JPEG
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 689
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 389
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 359
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 329
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 298
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 281
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 276
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 272
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 259
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 230
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 225
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 224
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 218
Ectopic fat is linked to prior cardiovascular events in men with HIV. 210
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 210
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 208
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 190
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 189
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 189
Hypokalemia in Patients with COVID-19 179
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 171
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 169
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 156
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 155
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 153
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 152
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol 152
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination 150
Peritoneal dialysis in the time of coronavirus disease 2019 147
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature 146
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 145
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 142
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality 141
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 139
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 138
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 138
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 133
Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection 132
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 130
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 128
Metabolic reprograming shapes neutrophil functions in severe COVID-19 126
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 126
A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program 125
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 125
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 123
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 121
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 119
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 117
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 113
Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in extensively drug-resistant (Xdr) and multidrug-resistant (mdr) pseudomonas aeruginosa: Resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs 103
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study) 102
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 99
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 95
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 95
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 94
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 90
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 89
The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae 88
Tocilizumab for severe COVID-19 pneumonia – Authors' reply 87
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 83
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 83
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) 81
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 78
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 78
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 74
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 72
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 70
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 68
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 68
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 67
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 65
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 65
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: a practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases 64
Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab 64
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 64
Continued decay of HIV proviral DNA upon vaccination with HIV-1 Tat of subjects on long-term ART: An 8-year follow-up study 63
Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study. 62
Re: 'methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' by Wolkewitz et al 59
Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia 59
Do all critically ill patients with COVID-19 disease benefit from adding tocilizumab to glucocorticoids? A retrospective cohort study. 58
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 51
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 48
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 47
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 47
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 44
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 38
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 37
New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA) 37
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 35
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 35
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 33
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 33
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 32
Reduction trend of mcr-1 circulation in Emilia-Romagna Region, Italy 32
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: The SALIR-E Study 29
Individual and collective impact of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in patients admitted to the ICU 29
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 28
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 26
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 25
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia 23
Totale 12.532
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.029
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020414 0 0 0 0 0 76 82 58 49 57 48 44
2020/20212.197 108 145 93 182 186 149 347 199 175 171 249 193
2021/20222.228 149 141 167 69 114 148 266 122 232 160 406 254
2022/20232.405 272 293 195 215 238 272 74 203 278 71 140 154
2023/20242.281 89 135 163 194 374 222 174 256 104 105 181 284
2024/20252.448 198 120 133 389 909 699 0 0 0 0 0 0
Totale 12.537